Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management

NCT: NCT07549737 · COMPLETED

NCT IDNCT07549737
StatusCOMPLETED
Start Date2024-07-17
Completion2025-08-23

Brief Summary

The purpose of this single arm clinical study is to find out how well two Silicone superabsorbent polymer dressings, RespoSorb Silicone (also known as Zetuvit Plus Silicone) and RespoSorb Silicone Border (also known as Zetuvit Plus Silicone Border), work in treating long lasting wounds on the lower legs or feet. The main goal of the study is to see whether these dressings help reduce wound size over time. The study also looks at whether the dressings improve the condition of the wound and the surrounding skin. In addition, patients are asked about their experience with the dressings, including whether they help reduce pain and how satisfied patients are with the treatment.

Frequently Asked Questions

What is Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management?

Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management is a clinical trial registered under NCT07549737. Current status: COMPLETED.

What is the status of NCT07549737?

The current status of NCT07549737 (Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management) is: COMPLETED.

When did Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management start?

Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management started on 2024-07-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.